Back
Masco Corp. 10K Form
Buy
51
MAS
Masco Corp.
Last Price:
$75.15
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-24 | 10Q | MAS/Masco Corp. Quarterly |
| 2024-02-08 | 10K | MAS/Masco Corp. Annual |
| 2023-10-26 | 10Q | MAS/Masco Corp. Quarterly |
| 2023-07-27 | 10Q | MAS/Masco Corp. Quarterly |
| 2023-04-26 | 10Q | MAS/Masco Corp. Quarterly |
| 2023-02-09 | 10K | MAS/Masco Corp. Annual |
Receive MAS News And Ratings
See the #1 stock for the next 7 days that we like better than MAS
MAS Financial Statistics
Sales & Book Value
| Annual Sales: | $7.6B |
|---|---|
| Cash Flow: | $371M |
| Price / Cash Flow: | 18.22 |
| Annual Sales: | $-0.91 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 3.85420 |
|---|---|
| Net Income (TTM): | $857M |
| Gross Margin: | $2.7B |
| Return on Equity: | 1286.79% |
| Return on Assets: | 16.53% |
Masco Corp. Earnings Forecast
Key Masco Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for MAS is 35.53%.
-
The Selling, General & Administrative Expenses for MAS have been equal to 18.86% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 11.77% of Operating Income.
-
The Net Earning history of MAS is 11.35% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 24 years.
Masco Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Building Products |
| Sector: | Industrials |
| Current Symbol: | MAS |
| CUSIP: | 574599 |
| Website: | masco.com |
Debt
| Debt-to-Equity Ratio: | -17.28 |
|---|---|
| Current Ratio: | 1.81 |
| Quick Ratio: | 1.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.48 |
|---|---|
| Forward P/E Ratio: | 16.25 |
MAS Technical Analysis vs Fundamental Analysis
Buy
51
Masco Corp. (MAS)
is a Buy
Is Masco Corp. a Buy or a Sell?
-
Masco Corp. stock is rated a BuyThe current Masco Corp. [MAS] share price is $75.15. The Score for MAS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.